CMS is taking aim at high insulin prices

The Center for Medicare and Medicaid Services is lining up drug makers and private insurers who manage Medicare drug benefits to volunteer to tests out a new pricing for insulin in 2021.  The program would create a flat monthly copayment rate of $35 for most types of insulin.  If it is successful for insulin, then expand the initiative to other drugs.  Currently, on average, people enrolled in Medicare pay about $675 per year for insulin. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.